At a glance
Overview
This monthly dashboard expands on the weekly COVID-19, flu, and RSV data available. It allows users to take a deeper dive into attitudes and behaviors associated with COVID-19, flu, and RSV vaccine uptake by a comprehensive set of demographic characteristics, behavioral and social drivers of vaccination, and barriers to vaccination.
Methods
Vaccination coverage estimates among adults 18 years and older are based on data from CDC's National Immunization Survey–Fall Respiratory Virus Module. Estimates of vaccination coverage are based on respondent self-report. Estimates of vaccination coverage on this dashboard may vary from estimates on the weekly dashboard: weekly estimates are derived from compiling interview data from all prior weeks, while monthly estimates are derived only from interviews conducted that month.
Data Summary
COVID-19 vaccine
- As of December 2025, 15.6% of adults 18 years and older, 20.4% of adults 18 – 64 years with high-risk conditions, and 32.4% of adults 65 years and older in the U.S. had received a 2025–26 COVID-19 vaccine.
- 9.6% of adults 18 years and older, 12.7% of adults 18 – 64 years with high-risk conditions, and 11.6% of adults 65 years and older reported that they definitely will get vaccinated with a 2025–26 COVID-19 vaccine.
- Nationally, adults who expressed moderate to high concern about getting COVID-19 disease are more likely to have received a 2025–26 COVID-19 vaccine compared with adults who expressed little to no concern (28.3% vs. 8.9%). Adults who considered the vaccine safe and who considered the vaccine important to protect them are also more likely to have received the 2025–26 COVID-19 vaccine (29.8% vs. 2.5% and 25.4% vs. 1.0%, respectively).
- The percent of adults reporting a healthcare provider had recommended COVID-19 vaccination this season was 19.4%.
Influenza vaccine
- As of December 2025, 40.2% of adults 18 years and older in the U.S. had received a 2025–26 flu vaccine.
- 8.2% of adults reported that they definitely will get vaccinated with a 2025–26 influenza vaccine.
- Nationally, adults who expressed moderate to high concern about getting flu are more likely to have received a 2025–26 flu vaccine compared with adults who expressed little to no concern (55.2% vs. 34.3%). Adults who considered the vaccine safe and who considered the vaccine important to protect them are also more likely to have received the 2025–26 vaccine (56.6% vs. 17.6% and 54.2% vs. 9.1%, respectively).
- The percent of adults reporting a healthcare provider had recommended flu vaccination this season was 42.8%.
RSV vaccine
- As of December 2025, RSV vaccination coverage was 43.4% among adults aged 75 years and older and 30.6% among those aged 50–74 years at increased risk of severe RSV disease.
- Among adults aged 75 years and older, 7.7% reported that they definitely will be vaccinated against RSV; among those aged 50–74 years at increased risk, 12.9% reported that they definitely will be vaccinated.
- Nationally, adults aged 75 years and older who expressed moderate to high concern about getting RSV were more likely to have received an RSV vaccine compared with adults who expressed little to no concern (55.9% vs. 38.1%). Adults who considered the vaccine safe and who considered the vaccine important to protect them were also more likely to have received the RSV vaccine (65.5% vs. 24.1% and 59.6% vs. 11.7%, respectively).
- The percent of adults reporting a healthcare provider had recommended RSV vaccination was 39.4% among adults aged 75 years and older and 35.7% among those aged 50–74 years at increased risk of severe RSV disease.